Key result
A patient with end-stage liver disease and a preoperative prolonged QT interval developed torsade de pointes during liver transplantation, which resolved after increasing heart rate with isoproterenol.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case represents the first report of torsade de pointes during liver transplantation in a patient with a preoperative prolonged QT interval, demonstrating successful management with isoproterenol to increase heart rate and shorten the QT interval.
Prolonged QT intervals have often been observed in patients with end-stage liver disease [1-3]. We present the first report of torsade de pointes during liver transplantation in a patient with a preoperative prolonged QT interval and increased QT dispersion. Case Report The patient was a 53-kg, 57-yr-old woman with Child-Pugh grade C alcohol-induced end-stage liver disease who was referred for orthotopic liver transplantation. The patient had a 90 pack/yr smoking history, mild chronic obstructive pulmonary disease, and a previous gunshot wound to the abdomen. Medications included omeprazole, lactulose, spironolactone, furosemide, ipratroprium, and albuterol. Preoperative evaluation included an electrocardiogram (EKG) with sinus rhythm at 66 bpm, a large U wave in lead V2, and an unrecognized mildly prolonged QTc interval of 0.53 s (normal <0.45 s) with QTc dispersion of 66 ms (normal 20-50 ms). An EKG obtained 1 yr earlier was similar, with a QTc interval of 0.50 s and QTc dispersion of 84 ms. The patient denied syncope or palpitations and had no family history of prolonged QT or sudden death. The patient was referred to a cardiologist because of increased pulmonary artery pressures detected by echocardiography. Preoperative right and left heart catheterizations revealed no significant coronary artery disease, normal left ventricular systolic function, mild pulmonary hypertension (35/20 mm Hg; normal 15-30/4-12 mm Hg), mildly increased left heart filling pressures (pulmonary wedge pressure and left ventricular end-diastolic pressure 19 mm Hg; normal 5-12 mm Hg), and an increased cardiac index (6.4 L [center dot] min-1 [center dot] m-2; normal 2.5-4.2 L [center dot] min-1 [center dot] m-2). Anesthesia for liver transplantation was induced with thiopental and succinylcholine and maintained with air/oxygen, isoflurane, remifentanil, and cisatracurium. The patient received magnesium 4 g IV to treat a serum magnesium level of 1.2 mEq/L (normal 1.3-1.9 mEq/L). The dissection and anhepatic stages were uneventful, and the patient remained stable with donor liver reperfusion. Standard immunosuppressive therapy was started (methylprednisolone and tacrolimus), and protamine, epsilon-aminocaproic acid, and platelets were given as dictated by the thromboelastogram and coagulation profiles. Within 90 min of reperfusion, there were signs of liver function: production of bile, decrease in serum lactate, and improvement in the thromboelastogram. The surgeons were dissatisfied with the portal vein anastomosis, and this was revised. A few minutes after the portal vein was unclamped, the patient developed multiple premature ventricular contractions (PVCs), which resolved with lidocaine 50 mg IV. The patient was hemodynamically stable with good oxygenation (saturation 100%) and ventilation (end-tidal CO2 30 mm Hg), and there were no ST changes on EKG monitoring. Laboratory values obtained at that time revealed normal blood electrolytes and acid-base status: potassium 3.9 mEq/L (normal 3.4-4.7 mEq/L), magnesium 1.4 mEq/L, ionized calcium 5.3 mg/dL (normal 4.75-5.20 mg/dL), pH 7.41 (normal 7.36-7.44), and base excess -1 mEq/L (normal 0 +/- 2 mEq/L). Eleven minutes later, anastomosis of the portal vein was redone; the patient again experienced multiple PVCs after unclamping. Two doses of lidocaine 50 mg IV did not result in improvement, and the ventricular ectopy worsened with frequent couplets and three-beat runs of monomorphic and then polymorphic ventricular tachycardia. The pulmonary artery catheter was repositioned and then removed, without benefit. Bretylium 250 mg, then 500 mg, and magnesium 5 g were administered IV, and procainamide 20 mg/min IV was begun; however, the ventricular ectopy worsened. Multiple PVCs and multiple episodes of 5- to 10-beat runs of polymorphic nonsustained ventricular tachycardia at rates of 150-225 bpm were observed. The patient had a normal blood pressure between runs of ventricular tachycardia, and repeat electrolytes and blood gas analysis were again normal. Esmolol 20 mg IV reduced the patient's heart rate to 40 bpm, which resulted in a predominant rhythm of ventricular tachycardia with occasionally interposed sinus beats. Careful review of the EKG revealed a prolonged QT interval (QT 0.60 s) and polymorphic ventricular tachycardia consistent with torsade de pointes (Figure 1). The procainamide was immediately discontinued (total dose 200 mg IV). The heart rate was increased to 100 bpm with the administration of glycopyrrolate 0.4 mg IV, which resulted in a marked decrease in ventricular ectopy. A continuous isoproterenol infusion was titrated (0.025-0.05 [micro sign]g [center dot] kg-1 [center dot] min-1) to resolution of ectopy: the heart rate increased to 115 bpm and the QT interval decreased to 0.38 s (Figure 2).Figure 1: Paper speed 25 mm/s. Leads II (top) and V5 (bottom). A, Ventricular bigeminy followed by an eight-beat run of torsade de pointes. Note the prolonged QT interval (0.60 s) of the sinus beats, the shifting of the electrical axis, and variable rate (150-214 bpm) of the tachycardia. B, Pause-dependent torsade de pointes. The long pause before sinus beats 2 and 5 followed by a three- and two-beat run of torsade de pointes, respectively. QT interval 0.56 s.Figure 2: Paper speed 25 mm/s. Lead II (top) and V5 (bottom). Patient receiving isoproterenol resulting in a sinus tachycardia of 115 bpm and QT interval of 0.38 s, with complete resolution of ventricular ectopy.Postoperatively, the patient's heart rate was maintained >100 bpm with isoproterenol until her QTc interval returned to normal 48 h later. The EKG at that time revealed normal sinus rhythm at 89 bpm with a QTc interval of 0.42 s (QT 0.34 s), and QTc dispersion of 50 ms. The patient's cardiac status remained stable. Discussion With a preoperative prolonged QT interval, prominent U wave, and increased QT dispersion, our patient had multiple intraoperative PVCs that progressed to a polymorphic ventricular tachycardia. The most common cause of polymorphic ventricular tachycardia is cardiac ischemia or infarction [4]; however, this patient had documented normal coronary arteries and no ST changes indicative of ischemia. The ventricular tachycardia was exacerbated by beta-blockade and improved by increasing the heart rate, neither of which would be expected in ischemic-induced ventricular tachycardia. This patient's arrhythmia was torsade de pointes, a form of polymorphic ventricular tachycardia occurring in the setting of a prolonged QT interval [5,6]. Other features consistent with torsade de pointes include the prominent U wave, exacerbation with pauses and lower heart rate (e.g., beta-blockade), resolution with increasing the heart rate (e.g., anticholinergics and catecholamines), shifting of electrical axis, and variable RR interval [6,7]. Torsade de pointes is most likely caused by early afterdepolarizations, which are depolarizations of the transmembrane voltage occurring during the plateau phase (phase 2) or early rapid repolarization phase (phase 3) of the purkinje fiber or ventricular muscle action potentials [8]. Decreasing net outward potassium current or increasing net inward sodium or calcium current during phase 2 delays repolarization and causes QT prolongation [7]. Class III antiarrhythmic drugs (e.g., bretylium) block potassium channels, and class IA drugs (e.g., procainamide, quinidine) block sodium channels, which may result in early afterdepolarizations and torsade de pointes [8]. Class II drugs (beta-blockers) slow the heart rate, which also prolongs repolarization. Class IB drugs (lidocaine) may suppress early afterdepolarizations and torsade de pointes, although they are not recommended as routine treatment because lidocaine itself can induce torsade de pointes [9]. Electrolyte abnormalities (hypokalemia, hypomagnesemia, and hypocalcemia) prolong repolarization and may also result in torsade de pointes [8]. QT dispersion is the difference between the maximal and minimal QT interval measured on a 12-lead EKG. Increased QT dispersion is caused by regional differences in repolarization and, like a prolonged QT interval, places the patient at increased risk of arrhythmias [10]. Increased QT dispersion may be a better indicator of risk for ventricular arrhythmias and torsade de pointes than prolonged QT interval [11-13]. In patients with a history of class IA drug-induced torsade de pointes, subsequent QT prolongation with chronic amiodarone therapy does not result in recurrent torsade de pointes, perhaps because the regional homogeneity effects of amiodarone do not increase QT dispersion despite increasing the QT interval [11]. Increased QT dispersion is usually caused by cardiac disease such as hypertrophic cardiomyopathy, mitral valve prolapse, or myocardial infarction [10]. In a study of patients presenting for liver transplantation, QT dispersion was >65 ms in 12% of patients and was highly predictive of liver storage or cardiac disease; however, our patient had neither of these abnormalities [14]. This patient's preoperative prolonged QT interval was likely secondary to the effects of cirrhosis. The patient had none of the other known causes of prolonged QT interval, including heredity (idiopathic long QT syndrome); drugs (e.g., antiarrhythmic drugs, phenothiazines, macrolide antibiotics, tricyclic antidepressants, nonsedating antihistamines); electrolyte disturbances; or cardiac, endocrine, or intracranial disorders [4,9,15,16]. QT interval prolongation has been reported in 47%-83% of patients presenting for orthotopic liver transplantation and is common in patients with alcohol-induced cirrhosis [1-3]. There is evidence that liver dysfunction causes prolongation of the QT interval: the degree of prolongation correlates with the severity of the liver disease, and the QT interval often returns to normal after liver transplantation [1]. Although the prolongation is not related to known causes, the precise etiology of prolonged QT interval in patients with liver failure has not been elucidated [1]. In addition to the prolonged QT interval associated with end-stage liver disease, patients presenting for liver transplantation are at additional risk of further QT prolongation. Most patients take diuretics preoperatively to control ascites, which may result in low magnesium and potassium levels. To lessen the impact of the hyperkalemic response to reperfusion intraoperatively, insulin and glucose are frequently administered to further lower the serum potassium level. Catecholamines such as epinephrine (to treat the post-reperfusion syndrome) or albuterol (to treat reactive airways) shift potassium intracellularly. Postoperatively, patients often become alkalotic as they metabolize citrate to bicarbonate, also resulting in reduced potassium levels. The rapid infusion of multiple blood products is likely to result in hypomagnesemia [17,18] or hypocalcemia secondary to the liver's inability to clear citrate. None of these electrolyte disturbances, however, was present in our patient. The unclamping of the portal vein twice preceded the onset of the arrhythmia in our patient; however, the donor liver had been perfused >90 min earlier, with complete washout of the preservative solution and no reperfusion syndrome. It is unclear why unclamping the portal vein was associated with the onset of torsade de pointes. Risk factors for the development of torsade de pointes in our patient included the preoperative prolonged QT interval, the marked variation in QT interval over time (from 0.48 s preoperatively to 0.60 s intraoperatively), and the increased QT dispersion [19]. The large U wave represented regions of late ventricular repolarization and also increased the risk of torsade de pointes [19]. It may be difficult initially to diagnose torsade de pointes because the arrhythmia may not take on its classic polymorphic nature until there are long runs of ventricular tachycardia; failure to promptly diagnose torsade de pointes could lead to its exacerbation, as in our patient [19]. Treatment of ventricular ectopy in patients with acquired prolonged QT intervals differs from treatment of ventricular ectopy in other patients. In all cases, standard causes of ectopy such as myocardial ischemia, acidosis, electrolyte disturbances, and mechanical irritation of the ventricle must be ruled out or treated. Although antiarrhythmic drugs in class IA suppress ventricular ectopy in patients with normal QT intervals, these drugs prolong the QT interval, increase QT dispersion, and can exacerbate torsade de pointes, as in our patient [10]. Although amiodarone is unlikely to cause torsade de pointes, other class III drugs, such as bretylium, are more likely to cause or aggravate torsade de pointes [20]. beta-blockade (class II) may be beneficial in suppressing ventricular ectopy caused by ischemia, sympathetic stimulation, or congenital prolonged QT syndrome; however, beta-blockade exacerbates ventricular tachycardia from acquired prolonged QT syndrome, especially in the setting of class IA and class III antiarrhythmic drugs [8]. IV magnesium 2-6 g often effectively suppresses torsade de pointes, even in patients with normal magnesium levels [21]; however, despite our patient receiving the recommended dose of magnesium, torsade de pointes persisted. The therapeutic effect of magnesium occurs without a decrease in the QT interval [8]. Our patient exhibited bradycardia-dependent torsade de pointes, which was effectively treated by increasing the heart rate with isoproterenol, which shortened the repolarization period and decreased the QT interval. Although the QTc interval changes minimally with changes in heart rate, the absolute QT interval is the more important factor in the genesis of torsade de pointes [19]. Because the patient's dysrhythmia was life-threatening and the isoproterenol was well tolerated, we continued the isoproterenol until the QTc interval normalized to reduce the risk of recurrent torsade de pointes [4,9]. Glycopyrrolate was initially used to increase the heart rate, but anticholinergic drugs frequently fail to maintain a constant rapid heart rate [7]. Cardiac pacing was another option and would have been initiated if the patient had not tolerated isoproterenol, or if the ectopy had persisted postoperatively after discontinuation of isoproterenol. Pacing at a rate of 90-100 bpm prevents postectopic pauses (which often precede torsade de pointes) and shortens the action potential, which prevents early afterdepolarizations [19]. Although atrial pacing is more physiologic and may be used if there is no atrioventricular block, right ventricular pacing is preferred because the ventricular electrode is more stable [7,9]. Our patient was in immediate need of treatment and we thought it was easier and faster to initiate isoproterenol than to place a temporary pacing wire, which often requires fluoroscopic guidance in the operating room. An anesthetic plan in patients with an acquired prolonged QT interval should attempt to limit further increases in the QT interval. Propofol has less QT-prolonging effect than thiopentone [22]. In a study of healthy patients who underwent an inhaled induction, maintenance with halothane prolonged the QT interval by approximately 0.07 s, whereas isoflurane had no significant effect [23]. Bradycardia (e.g., from large doses of opioids, beta-blockade, or insufficient anticholinergic dosing after muscle relaxation reversal) also prolongs the QT interval. Perioperative droperidol to control nausea, or postoperative haloperidol for intensive care unit sedation should be used cautiously in patients with prolonged QT interval because phenothiazines also prolong the QT interval [24]. This case demonstrates the importance of identifying prolonged QT intervals, U waves, and increased QT dispersion in patients with liver failure presenting for surgery. If these abnormalities are not identified preoperatively, perioperative management could further prolong the QT interval and increase the risk of torsade de pointes. Steps should be taken perioperatively to ensure that patients with a prolonged QT interval do not develop electrolyte disturbances or receive drugs that further prolong the QT interval or induce bradycardia. If torsade de pointes occurs, treatment should include administering magnesium and decreasing the QT interval by increasing the heart rate.
No takes yet. Share an insight, caveat, or question.
Lustik et al. (1998) conducted a case report in End-stage liver disease (n=1). Orthotopic liver transplantation was evaluated. A patient with end-stage liver disease and a preoperative prolonged QT interval developed torsade de pointes during liver transplantation, which resolved after increasing heart rate with isoproterenol.
Synapse has enriched 10 related papers. Consider them for comparative context: